XML 43 R32.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Summary of Significant Accounting Policies (Details) - USD ($) |  |  | 3 Months Ended | 6 Months Ended | 12 Months Ended |
--- | --- | --- | --- | --- | --- | ---
Aug. 12, 2024 | Aug. 02, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | Dec. 31, 2023 | Jan. 29, 2024
Summary of Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |
Inventory write-downs (in Dollars) |  |  | $ 16,684 | $ 111,220 | $ 17,325 | $ 116,611 |  |
Research and development costs (in Dollars) |  |  | $ 3,095,326 | $ 203,872 | $ 3,432,508 | $ 327,866 |  |
Exercise price per share (in Dollars per share) |  |  | $ 0.12 |  | $ 0.12 |  |  | $ 0.12
60P Australia Pty Ltd [Member] | Geoffrey Dow [Member] |  |  |  |  |  |  |  |
Summary of Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |
Number of common shares issued (in Shares) |  | 904,436 |  |  |  |  |  |
American Pharmaceutical Distributor [Member] |  |  |  |  |  |  |  |
Summary of Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |
Percentage of accounts receivable |  |  | 96.00% |  | 96.00% |  | 79.00% |
US Government Accounted [Member] |  |  |  |  |  |  |  |
Summary of Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |
Outstanding accounts receivable percentage |  |  |  |  |  |  | 13.00% |
Subsequent Event [Member] |  |  |  |  |  |  |  |
Summary of Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |
Reverse stock split | the Company effected a reverse stock split at a ratio of 1:12 (the “Reverse Stock Split”) |  |  |  |  |  |  |
60P Australia Pty Ltd [Member] | Minimum [Member] |  |  |  |  |  |  |  |
Summary of Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |
Ownership percentage |  | 87.53% |  |  |  |  |  |
60P Australia Pty Ltd [Member] | Maximum [Member] |  |  |  |  |  |  |  |
Summary of Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |
Ownership percentage |  | 96.61% |  |  |  |  |  |
Single Customers One [Member] | Revenue from Rights Concentration Risk [Member] | Revenue Benchmark [Member] |  |  |  |  |  |  |  |
Summary of Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |
Concentration risk, percentage |  |  |  |  | 100.00% |  |  |
Single Customers Two [Member] | Revenue from Rights Concentration Risk [Member] | Revenue Benchmark [Member] |  |  |  |  |  |  |  |
Summary of Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |
Concentration risk, percentage |  |  |  |  | 96.00% |  |  |
Single Customers Three [Member] | Revenue from Rights Concentration Risk [Member] | Revenue Benchmark [Member] |  |  |  |  |  |  |  |
Summary of Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |
Concentration risk, percentage |  |  |  |  |  |  | 92.00% |
Customer One [Member] | Revenue from Rights Concentration Risk [Member] | Revenue Benchmark [Member] |  |  |  |  |  |  |  |
Summary of Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |
Concentration risk, percentage |  |  |  |  |  |  | 79.00% |
Customer Two [Member] | Revenue from Rights Concentration Risk [Member] | Revenue Benchmark [Member] |  |  |  |  |  |  |  |
Summary of Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |
Concentration risk, percentage |  |  |  |  |  |  | 13.00% |
Receivable [Member] | Revenue from Rights Concentration Risk [Member] | Revenue Benchmark [Member] |  |  |  |  |  |  |  |
Summary of Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |
Concentration risk, percentage |  |  | 92.00% |  |  |  |  |
Single Customers Four [Member] | Revenue from Rights Concentration Risk [Member] | Revenue Benchmark [Member] |  |  |  |  |  |  |  |
Summary of Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |
Concentration risk, percentage |  |  | 3.00% |  | 95.00% |  |  |
Significant Customers [Member] | Revenue from Rights Concentration Risk [Member] | Revenue Benchmark [Member] |  |  |  |  |  |  |  |
Summary of Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |
Concentration risk, percentage |  |  | 100.00% |  | 100.00% |  |  |

X
- Definition Percentage of outstanding accounts receivable. + References No definition available. + Details
Name: | sxtp_OutstandingAccountsReceivablePercentage
Namespace Prefix: | sxtp_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Percentage of accounts receivable. + References No definition available. + Details
Name: | sxtp_PercentageOfAccountsReceivable
Namespace Prefix: | sxtp_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | instant

X
- References No definition available. + Details
Name: | sxtp_SummaryofSignificantAccountingPoliciesDetailsLineItems
Namespace Prefix: | sxtp_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-20 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20 + Details
Name: | us-gaap_ConcentrationRiskPercentage1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3 + Details
Name: | us-gaap_EquityMethodInvestmentOwnershipPercentage
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 330 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483080/330-10-50-2 + Details
Name: | us-gaap_InventoryWriteDown
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 48 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 985 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 730 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 912 -SubTopic 730 -Name Accounting Standards Codification -Section 25 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1 + Details
Name: | us-gaap_ResearchAndDevelopmentExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Per share or per unit amount of equity securities issued. + References No definition available. + Details
Name: | us-gaap_SharesIssuedPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of new stock issued during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(4)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 4 -Subparagraph (SAB Topic 4.C) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-4 + Details
Name: | us-gaap_StockholdersEquityReverseStockSplit
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=sxtp_SixZeroPAustraliaPtyLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=sxtp_GeoffreyDowMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis=sxtp_AmericanPharmaceuticalDistributorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis=sxtp_USGovernmentAccountedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=sxtp_SixZeroPAustraliaPtyLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=sxtp_SingleCustomersOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=us-gaap_RevenueFromRightsConcentrationRiskMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=sxtp_SingleCustomersTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=sxtp_SingleCustomersThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=sxtp_CustomerOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=sxtp_CustomerTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=sxtp_ReceivableMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=sxtp_SingleCustomersFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=sxtp_SignificantCustomersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |